Palvella Therapeutics, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Palvella Therapeutics, Inc. (PVLA) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $55.20 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-04
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $55.20M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $51.60M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $30.10M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $20.50M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $55.20M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $51.60M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $30.10M 10-K · filed 2026-03-31 |
| 2025-09-30 | $20.50M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $20.10M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $18.00M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $10.60M 10-K · filed 2025-03-31 |
| 2015-09-30 | $3.80M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $2.25M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $2.41M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $2.59M 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |